nystatin-a1 and Tympanic-Membrane-Perforation

In patients with a perforated tympanic membrane, topically administered medication reaches the middle ear and thus creates a risk of ototoxicity. The aim of the present study was to evaluate the possible ototoxic effect of the antifungal medication nystatin when administered to the rat middle ear cavity.. Three groups (negative control, positive control, and study groups), each containing eight rats, were formed. Before the drug administration, distortion product otoacoustic emissions were recorded in both ears of each rat. Saline (0.09% NaCl), gentamycin, and nystatin solutions were transtympanically injected into the middle ear cavities of the negative control, positive control, and study groups, respectively, for five consecutive days. Seven days after the last infiltration, the control otoacoustic emission was measured, and the data of the 2, 3, 4, 6, 8 kHz frequencies were statistically analyzed.. There were no significant changes between the 1st and 2nd measures in the negative control group (0.09% NaCl) (p>0.05), whereas there were significant changes between the 1st and 2nd measures in the positive control group (gentamycin) and study group (nystatin) (p<0.05).. Ototopical medications carry a risk of ototoxicity in patients with perforated ear drums. In the present study, it was shown that nystatin, an antifungal that can be ototopically used in the treatment of otomycosis, may cause a decrease in otoacoustic emissions in rats when administered into the middle ear cavities.

Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Cochlea; Disease Models, Animal; Ear, Middle; Gentamicins; Nystatin; Otoacoustic Emissions, Spontaneous; Random Allocation; Rats; Tympanic Membrane; Tympanic Membrane Perforation

Nystatin is a topical antifungal agent. Its wide spectrum of action and low cost make it a treatment of choice. Though it is safe for external ear use, no study has proven its safety in cases of tympanic membrane perforation (TMP). We aim to test the safety of Nystatin when applied directly to the middle ear of a Guinea Pig model. We performed an experimental study with 18 Hartley Guinea Pigs that were divided into two groups. All tympanic membranes were perforated at the beginning of the study. Exposing one group to Nystatin and the other to the ototoxic Neomycin, we compared results of auditory brainstem response testing at three intervals. Each animals' contralateral ear was used as a negative control. At the end, we performed a histological analysis of the animals' cochleae using a scanning electron microscope (SEM). Average hearing loss in the Nystatin group was 13.0 dB which was similar to the results obtained in the negative control group (13.1 dB). Average hearing loss in the Neomycin group was 39.3 dB, which represents a statistically significant difference (P < 0.001). SEM evaluation revealed intact cochlear hair cell architecture in the Nystatin and normal saline groups, whereas significant hair cell losses were noted in the Neomycin group was noted. Nystatin does not cause hearing impairment or cochlear hair cell damage when exposed directly to the middle ear of a Guinea Pig model. It is therefore a safe treatment option for otomycosis with presence of TMP.

Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Antifungal Agents; Bacitracin; Cochlea; Drug Combinations; Ear, Inner; Electroencephalography; Evoked Potentials, Auditory, Brain Stem; Functional Laterality; Guinea Pigs; Hair Cells, Auditory; Microscopy, Electron, Scanning; Neomycin; Nystatin; Polymyxin B; Tympanic Membrane; Tympanic Membrane Perforation

To assess the myringoplasty graft take rate, comparing two methods of post-operative ear packing: bismuth iodoform paraffin paste (BIPP) gauze versus tri-adcortyl ointment (TAO).. A retrospective study of patients who had undergone myringoplasty at our department within a three-year period was undertaken. Data, including age, site and size of perforation, grade of surgeon, surgical approach, use of post-operative ear dressings, complications, and audiometric outcome, were collected from the patient notes and analysed. The overall success rate of the operation (with success being defined as an intact tympanic membrane at six months) was noted.. One hundred and seventy myringoplasties were performed over the study period, but data were complete on 154 patients and these constituted the study population. Age ranged from nine to 71 years (mean age 34 years) and the mean follow-up period was seven months. Consultants performed 62 per cent of the operations, with an 85 per cent success rate, whereas trainees performed the remaining 38 per cent, with a success rate of 73 per cent (p=0.059). The overall success rate was 80 per cent; 79 per cent for BIPP and 83 per cent for TAO (p=0.55), and 87 per cent for small perforations and 75 per cent for subtotal perforations (p=0.22). There was audiometric improvement in 74 per cent of cases.. We found no significant difference in outcome between patients packed with TAO and BIPP. Packing with TAO is therefore a suitable alternative to BIPP gauze ear dressing following myringoplasty.

Topics: Adolescent; Adult; Aged; Bandages; Bismuth; Child; Drug Combinations; Female; Gramicidin; Humans; Hydrocarbons, Iodinated; Male; Middle Aged; Myringoplasty; Neomycin; Nystatin; Ointments; Postoperative Care; Retrospective Studies; Triamcinolone Acetonide; Tympanic Membrane Perforation; Wound Healing

In a retrospective study of patients who had undergone myringoplasty at our department within a 12-month period, we assessed the graft take rate using tri-adcortyl ointment (TAO) as ear dressing. Data including age, site and size of perforation, grade of surgeon, surgical approach, use of postoperative ear dressings, complications and audiometric outcome was collected from the patient notes and analysed. The overall success rate of the operation (with success being defined as an intact tympanic membrane at 6 months) was noted. Seventy-seven patients were operated, but data were complete on 64 patients and these constituted the study population. TAO was used in 95% of the patients and BIPP gauze pack in the remaining 5%. Age ranged from 8 to 63 years (mean 34 years). Mean follow-up period was 13 months. Most of the operations (72.88%) were carried out by consultants with a success rate of 89% and the remaining patients were operated by trainees with a success rate of 88% (P = 1.000). The overall success rate was 89, 90.16% for TAO and 66.66% (2 out of 3) for BIPP (P = 0.298), 95% for small and 86% for subtotal perforations (P = 0.573), 85% for anterior and 100% for posterior perforations (P = 0.240), 91% for adult patients and 88% for children (P = 1.000). TAO is a suitable ear dressing in myringoplasty. Routine use of TAO did not affect the success rate of myringoplasty at our centre.

Topics: Adolescent; Adult; Aged; Audiometry; Child; Drug Combinations; Female; Follow-Up Studies; Gramicidin; Hearing; Humans; Male; Middle Aged; Myringoplasty; Neomycin; Nystatin; Occlusive Dressings; Ointments; Otitis Media; Retrospective Studies; Rupture, Spontaneous; Treatment Outcome; Triamcinolone Acetonide; Tympanic Membrane Perforation

Although rare, ototoxicity from the use of aminoglycoside drops is well recognized. Ototoxicity has not been described with the use of combination aminoglycoside-steroid-antifungal creams or ointments. We present the case of a 60-year-old man with a perforated tympanic membrane who suffered a total hearing loss after the instillation of cream containing triamcinolone, neomycin, gramicidin and nystatin (Tri-Adcortyl cream) into his ear canal. On balance, we believe that a number of potentially ototoxic constituents in this cream were responsible. Other possible causes of sensorineural hearing loss and the possible mechanisms of ototoxicity of this cream are discussed. The reasons why such creams may be particularly ototoxic, compared with drops, are also considered. The authors caution against the use of such creams or ointments in the ear if there is any suspicion of a tympanic membrane perforation.

Topics: Administration, Topical; Anti-Bacterial Agents; Anti-Inflammatory Agents; Deafness; Drug Combinations; Drug Therapy, Combination; Gramicidin; Humans; Male; Middle Aged; Neomycin; Nystatin; Triamcinolone Acetonide; Tympanic Membrane Perforation